Friday 31 December 2010

Magaldrat-ratiopharm




Magaldrat-ratiopharm may be available in the countries listed below.


Ingredient matches for Magaldrat-ratiopharm



Magaldrate

Magaldrate is reported as an ingredient of Magaldrat-ratiopharm in the following countries:


  • Germany

International Drug Name Search

Tuesday 28 December 2010

Gertalgin




Gertalgin may be available in the countries listed below.


Ingredient matches for Gertalgin



Omeprazole

Omeprazole is reported as an ingredient of Gertalgin in the following countries:


  • Greece

International Drug Name Search

Thursday 23 December 2010

Linopril




Linopril may be available in the countries listed below.


Ingredient matches for Linopril



Lisinopril

Lisinopril is reported as an ingredient of Linopril in the following countries:


  • Bahrain

  • Oman

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Linopril in the following countries:


  • Vietnam

International Drug Name Search

Wednesday 22 December 2010

Benzith




Benzith may be available in the countries listed below.


Ingredient matches for Benzith



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Benzith in the following countries:


  • Bangladesh

Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Benzith in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday 21 December 2010

Paroxetina Rimafar




Paroxetina Rimafar may be available in the countries listed below.


Ingredient matches for Paroxetina Rimafar



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Rimafar in the following countries:


  • Spain

International Drug Name Search

Sunday 19 December 2010

Keftaz




Keftaz may be available in the countries listed below.


Ingredient matches for Keftaz



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Keftaz in the following countries:


  • South Africa

International Drug Name Search

Monday 13 December 2010

Himitan




Himitan may be available in the countries listed below.


Ingredient matches for Himitan



Pyridoxal Phosphate

Pyridoxal Phosphate is reported as an ingredient of Himitan in the following countries:


  • Japan

International Drug Name Search

Wednesday 8 December 2010

Fulpen




Fulpen may be available in the countries listed below.


Ingredient matches for Fulpen



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Fulpen in the following countries:


  • Japan

International Drug Name Search

Tuesday 7 December 2010

Loratadine Generics




Loratadine Generics may be available in the countries listed below.


Ingredient matches for Loratadine Generics



Loratadine

Loratadine is reported as an ingredient of Loratadine Generics in the following countries:


  • Greece

International Drug Name Search

Wednesday 24 November 2010

Glibornuride




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BB04

CAS registry number (Chemical Abstracts Service)

0026944-48-9

Chemical Formula

C18-H26-N2-O4-S

Molecular Weight

366

Therapeutic Category

Oral antidiabetic agent, sulfonylurea

Chemical Name

Benzenesulfonamide, N-[[(3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]hept-2-yl)amino]carbonyl]-4-methyl-, [1S-(endo,endo)]-

Foreign Names

  • Glibornuridum (Latin)
  • Glibornurid (German)
  • Glibornuride (French)
  • Glibornurida (Spanish)

Generic Names

  • Glibornuride (OS: BAN, USAN, DCF)
  • Ro 6-4563 (IS: HoffmannLaRoc)

Brand Names

  • Glutril
    Meda, France; Onko-Koçsel, Turkey; Valeant Pharmaceuticals Switzerland GmbH, Switzerland

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 18 November 2010

Deidrochin




Deidrochin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Deidrochin



Sulfaquinoxaline

Sulfaquinoxaline is reported as an ingredient of Deidrochin in the following countries:


  • Italy

International Drug Name Search

Monday 15 November 2010

Lisonin




Lisonin may be available in the countries listed below.


Ingredient matches for Lisonin



Lincomycin

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lisonin in the following countries:


  • Mexico

International Drug Name Search

Saturday 13 November 2010

Trioxsalen




In the US, Trioxsalen (trioxsalen systemic) is a member of the drug class psoralens.

US matches:

  • Trioxsalen

Ingredient matches for Trioxsalen



Trioxysalen

Trioxsalen (USAN) is also known as Trioxysalen (Rec.INN)

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 10 November 2010

Lincomix




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Lincomix



Buquinolate

Buquinolate is reported as an ingredient of Lincomix in the following countries:


  • United States

Clopidol

Clopidol is reported as an ingredient of Lincomix in the following countries:


  • United States

Decoquinate

Decoquinate is reported as an ingredient of Lincomix in the following countries:


  • United States

Dinitolmide

Dinitolmide is reported as an ingredient of Lincomix in the following countries:


  • United States

Fenbendazole

Fenbendazole is reported as an ingredient of Lincomix in the following countries:


  • United States

Halofuginone

Halofuginone hydrobromide (a derivative of Halofuginone) is reported as an ingredient of Lincomix in the following countries:


  • United States

Lasalocid

Lasalocid is reported as an ingredient of Lincomix in the following countries:


  • United States

Lincomycin

Lincomycin is reported as an ingredient of Lincomix in the following countries:


  • New Zealand

  • United States

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lincomix in the following countries:


  • Australia

  • Belgium

  • Finland

  • Netherlands

  • United States

Monensin

Monensin is reported as an ingredient of Lincomix in the following countries:


  • United States

Monensin sodium salt (a derivative of Monensin) is reported as an ingredient of Lincomix in the following countries:


  • United States

Nicarbazin

Nicarbazin is reported as an ingredient of Lincomix in the following countries:


  • United States

Pyrantel

Pyrantel tartrate (a derivative of Pyrantel) is reported as an ingredient of Lincomix in the following countries:


  • United States

Robenidine

Robenidine hydrochloride (a derivative of Robenidine) is reported as an ingredient of Lincomix in the following countries:


  • United States

Salinomycin

Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of Lincomix in the following countries:


  • United States

International Drug Name Search

Ferreux (gluconate)




Ferreux (gluconate) may be available in the countries listed below.


Ingredient matches for Ferreux (gluconate)



Ferrous Gluconate

Ferreux (gluconate) (DCF) is known as Ferrous Gluconate in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Lanximed




Lanximed may be available in the countries listed below.


Ingredient matches for Lanximed



Lansoprazole

Lansoprazole is reported as an ingredient of Lanximed in the following countries:


  • Colombia

International Drug Name Search

Thursday 4 November 2010

Caparsolate Sodium




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Caparsolate Sodium



Thiacetarsamide Sodium

Thiacetarsamide Sodium is reported as an ingredient of Caparsolate Sodium in the following countries:


  • United States

International Drug Name Search

Rakudeen




Rakudeen may be available in the countries listed below.


Ingredient matches for Rakudeen



Spironolactone

Spironolactone is reported as an ingredient of Rakudeen in the following countries:


  • Japan

International Drug Name Search

Wednesday 27 October 2010

Dynex VR Sustained-Release Capsules


Pronunciation: car-bay-ta-PEN-tane/gwye-FEN-eh-sin
Generic Name: Carbetapentane/Guaifenesin
Brand Name: Dynex VR


Dynex VR Sustained-Release Capsules are used for:

Relieving unproductive cough and reducing mucus in the chest due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.


Dynex VR Sustained-Release Capsules are a cough suppressant and expectorant combination. The cough suppressant works in the brain to help decrease the cough reflex. The expectorant works by thinning mucus (phlegm) in the lungs, making it less sticky and easier to cough up. This makes coughs more productive.


Do NOT use Dynex VR Sustained-Release Capsules if:


  • you are allergic to any ingredient in Dynex VR Sustained-Release Capsules

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dynex VR Sustained-Release Capsules:


Some medical conditions may interact with Dynex VR Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have chronic cough due to smoking, asthma, chronic bronchitis, or emphysema, or if your cough produces large amounts of mucus

  • if you have a history of heart problems, high blood pressure, prostate problems, an overactive thyroid, diabetes, or glaucoma

Some MEDICINES MAY INTERACT with Dynex VR Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines. However, no specific interactions with Dynex VR Sustained-Release Capsules are known at this time.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Dynex VR Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dynex VR Sustained-Release Capsules:


Use Dynex VR Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dynex VR Sustained-Release Capsules may be taken with or without food.

  • Drinking extra fluids while you are taking Dynex VR Sustained-Release Capsules are recommended. Check with your doctor for instructions.

  • Swallow Dynex VR Sustained-Release Capsules whole. Do not break, crush, or chew before swallowing.

  • If you miss a dose of Dynex VR Sustained-Release Capsules and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dynex VR Sustained-Release Capsules.



Important safety information:


  • Dynex VR Sustained-Release Capsules may cause drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dynex VR Sustained-Release Capsules. Using Dynex VR Sustained-Release Capsules alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Avoid drinking alcohol or taking other medications that cause drowsiness (eg, sedatives, tranquilizers) while taking Dynex VR Sustained-Release Capsules. Dynex VR Sustained-Release Capsules will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants.

  • If cough persists for more than 1 week or is accompanied by a fever, contact your health care provider. A persistent cough could be a sign of a serious condition.

  • Dynex VR Sustained-Release Capsules are not recommended for use in CHILDREN younger than 6 years of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Dynex VR Sustained-Release Capsules during pregnancy. It is unknown if Dynex VR Sustained-Release Capsules are excreted in breast milk. If you are or will be breast-feeding while you are using Dynex VR Sustained-Release Capsules, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Dynex VR Sustained-Release Capsules:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Drowsiness; dry mouth, nose, or throat; upset stomach.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dynex VR side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include restlessness; seizures; severe agitation.


Proper storage of Dynex VR Sustained-Release Capsules:

Store Dynex VR Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dynex VR Sustained-Release Capsules out of the reach of children and away from pets.


General information:


  • If you have any questions about Dynex VR Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.

  • Dynex VR Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dynex VR Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dynex VR resources


  • Dynex VR Side Effects (in more detail)
  • Dynex VR Use in Pregnancy & Breastfeeding
  • Dynex VR Drug Interactions
  • Dynex VR Support Group
  • 0 Reviews for Dynex VR - Add your own review/rating


Compare Dynex VR with other medications


  • Cough

Miozac




Miozac may be available in the countries listed below.


Ingredient matches for Miozac



Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Miozac in the following countries:


  • Italy

International Drug Name Search

Monday 11 October 2010

Aphenylbarbit




Aphenylbarbit may be available in the countries listed below.


Ingredient matches for Aphenylbarbit



Phenobarbital

Phenobarbital is reported as an ingredient of Aphenylbarbit in the following countries:


  • Switzerland

International Drug Name Search

Wednesday 6 October 2010

Levolacin




Levolacin may be available in the countries listed below.


Ingredient matches for Levolacin



Levofloxacin

Levofloxacin is reported as an ingredient of Levolacin in the following countries:


  • Greece

International Drug Name Search

Sunday 3 October 2010

Probalan




Ingredient matches for Probalan



Probenecid

Probenecid is reported as an ingredient of Probalan in the following countries:


  • United States

International Drug Name Search

Thursday 16 September 2010

Lisinopril-Teva comp.




Lisinopril-Teva comp. may be available in the countries listed below.


Ingredient matches for Lisinopril-Teva comp.



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril-Teva comp. in the following countries:


  • Germany

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril-Teva comp. in the following countries:


  • Germany

International Drug Name Search

Calutide




Calutide may be available in the countries listed below.


Ingredient matches for Calutide



Bicalutamide

Bicalutamide is reported as an ingredient of Calutide in the following countries:


  • Bulgaria

International Drug Name Search

Monday 13 September 2010

Carnaculin




Carnaculin may be available in the countries listed below.


Ingredient matches for Carnaculin



Kallidinogenase

Kallidinogenase is reported as an ingredient of Carnaculin in the following countries:


  • Japan

International Drug Name Search

Friday 10 September 2010

Sogécycline




Sogécycline may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sogécycline



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Sogécycline in the following countries:


  • France

International Drug Name Search

Monday 6 September 2010

AK-Tob




In the US, AK-Tob (tobramycin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis, Bacterial.

US matches:

  • AK-Tob Drops

  • AK-Tob

Ingredient matches for AK-Tob



Tobramycin

Tobramycin is reported as an ingredient of AK-Tob in the following countries:


  • United States

International Drug Name Search

Sunday 5 September 2010

Lithioderm




Lithioderm may be available in the countries listed below.


Ingredient matches for Lithioderm



Lithium

Lithium gluconate (a derivative of Lithium) is reported as an ingredient of Lithioderm in the following countries:


  • France

International Drug Name Search

Saturday 4 September 2010

Allopurinol Teva




Allopurinol Teva may be available in the countries listed below.


Ingredient matches for Allopurinol Teva



Allopurinol

Allopurinol is reported as an ingredient of Allopurinol Teva in the following countries:


  • France

  • Switzerland

International Drug Name Search

Tuesday 24 August 2010

Triostat




In the US, Triostat (liothyronine systemic) is a member of the drug class thyroid drugs and is used to treat Hypothyroidism - After Thyroid Removal, Myxedema, Myxedema Coma, Thyroid Suppression Test, TSH Suppression and Underactive Thyroid.

US matches:

  • Triostat

Ingredient matches for Triostat



Liothyronine

Liothyronine sodium salt (a derivative of Liothyronine) is reported as an ingredient of Triostat in the following countries:


  • United States

International Drug Name Search

Thursday 12 August 2010

Maxicardil




Maxicardil may be available in the countries listed below.


Ingredient matches for Maxicardil



Dipyridamole

Dipyridamole is reported as an ingredient of Maxicardil in the following countries:


  • Argentina

International Drug Name Search

Tuesday 10 August 2010

Fluorouracilo Filaxis




Fluorouracilo Filaxis may be available in the countries listed below.


Ingredient matches for Fluorouracilo Filaxis



Fluorouracil

Fluorouracil is reported as an ingredient of Fluorouracilo Filaxis in the following countries:


  • Argentina

International Drug Name Search

Sunday 8 August 2010

Liberanit




Liberanit may be available in the countries listed below.


Ingredient matches for Liberanit



Acetic Acid

Acetic Acid 4% (a derivative of Acetic Acid) is reported as an ingredient of Liberanit in the following countries:


  • Germany

International Drug Name Search

Extal




Extal may be available in the countries listed below.


Ingredient matches for Extal



Acetylcysteine

Acetylcysteine is reported as an ingredient of Extal in the following countries:


  • Turkey

International Drug Name Search

Saturday 7 August 2010

Zostydol




Zostydol may be available in the countries listed below.


Ingredient matches for Zostydol



Brivudine

Brivudine is reported as an ingredient of Zostydol in the following countries:


  • Argentina

International Drug Name Search

Thursday 5 August 2010

Lax




Lax may be available in the countries listed below.


Ingredient matches for Lax



Lactulose

Lactulose is reported as an ingredient of Lax in the following countries:


  • Bangladesh

International Drug Name Search

Saturday 31 July 2010

Vogalib




Vogalib may be available in the countries listed below.


Ingredient matches for Vogalib



Metopimazine

Metopimazine is reported as an ingredient of Vogalib in the following countries:


  • France

International Drug Name Search

Sunday 25 July 2010

Ampisina




Ampisina may be available in the countries listed below.


Ingredient matches for Ampisina



Ampicillin

Ampicillin is reported as an ingredient of Ampisina in the following countries:


  • Turkey

International Drug Name Search

Friday 23 July 2010

Alcon Ciloxan




Alcon Ciloxan may be available in the countries listed below.


Ingredient matches for Alcon Ciloxan



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Alcon Ciloxan in the following countries:


  • Romania

International Drug Name Search

Wednesday 21 July 2010

Hyaluronidase (Ovine)




Hyaluronidase (Ovine) may be available in the countries listed below.


Ingredient matches for Hyaluronidase (Ovine)



Hyaluronidase

Hyaluronidase (Ovine) (USAN) is known as Hyaluronidase in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 20 July 2010

Oprezol




Oprezol may be available in the countries listed below.


Ingredient matches for Oprezol



Omeprazole

Omeprazole is reported as an ingredient of Oprezol in the following countries:


  • Indonesia

International Drug Name Search

Sunday 11 July 2010

Panretin


Panretin is a brand name of alitretinoin topical, approved by the FDA in the following formulation(s):


PANRETIN (alitretinoin - gel; topical)



  • Manufacturer: EISAI INC

    Approval date: February 2, 1999

    Strength(s): EQ 0.1% BASE [RLD]

Has a generic version of Panretin been approved?


No. There is currently no therapeutically equivalent version of Panretin available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Panretin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
    Patent 5,932,622
    Issued: August 3, 1999
    Inventor(s): Evans; Ronald M. & Mangelsdorf; David J. & Heyman; Richard A. & Boehm; Marcus F. & Eichele; Gregor & Thaller; Christina
    Assignee(s): The Salk Institute for Biological Studies
    Baylor College of Medicine
    Ligand Pharmaceuticals, Inc.
    A method for modulating non-malignant skin related disorders in a subject has been demonstrated with 9-cis retinoic acid. Wrinkling, acne, keratinization, differentiation and proliferation disorders are treated by administration of 9-cis retinoic acid alone or in a pharmaceutically acceptable carrier to a subject in need thereof.
    Patent expiration dates:

    • August 3, 2016
      ✓ 
      Patent use: TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA



See also...

  • Panretin Consumer Information (Wolters Kluwer)
  • Panretin Consumer Information (Cerner Multum)
  • Panretin Topical Advanced Consumer Information (Micromedex)
  • Panretin AHFS DI Monographs (ASHP)
  • Alitretinoin Consumer Information (Wolters Kluwer)
  • Alitretinoin topical Consumer Information (Cerner Multum)
  • Alitretinoin Topical Advanced Consumer Information (Micromedex)
  • Alitretinoin AHFS DI Monographs (ASHP)

Baby Pig Premix




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Baby Pig Premix



Tylosin

Tylosin phosphate (a derivative of Tylosin) is reported as an ingredient of Baby Pig Premix in the following countries:


  • United States

International Drug Name Search

Saturday 10 July 2010

Potassium Bitartrate




Potassium Bitartrate may be available in the countries listed below.


Ingredient matches for Potassium Bitartrate



Potassium Hydrogen Tartrate

Potassium Bitartrate (USAN) is also known as Potassium Hydrogen Tartrate (Ph. Eur.)

International Drug Name Search

Glossary

Ph. Eur.European Pharmacopoeia
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 8 July 2010

Lapicrine




Lapicrine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Lapicrine



Sulfadimidine

Sulfadimidine sodium salt (a derivative of Sulfadimidine) is reported as an ingredient of Lapicrine in the following countries:


  • France

Sulfaquinoxaline

Sulfaquinoxaline sodium salt (a derivative of Sulfaquinoxaline) is reported as an ingredient of Lapicrine in the following countries:


  • France

International Drug Name Search

Saturday 3 July 2010

Pulneo




Pulneo may be available in the countries listed below.


Ingredient matches for Pulneo



Fenspiride

Fenspiride hydrochloride (a derivative of Fenspiride) is reported as an ingredient of Pulneo in the following countries:


  • Poland

International Drug Name Search

Thursday 24 June 2010

Riz




Riz may be available in the countries listed below.


Ingredient matches for Riz



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Riz in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday 22 June 2010

Mamasan




Mamasan may be available in the countries listed below.


Ingredient matches for Mamasan



Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Mamasan in the following countries:


  • Argentina

International Drug Name Search

Cimexol




Cimexol may be available in the countries listed below.


Ingredient matches for Cimexol



Cimetidine

Cimetidine is reported as an ingredient of Cimexol in the following countries:


  • Indonesia

International Drug Name Search

Sunday 20 June 2010

Lecarge




Lecarge may be available in the countries listed below.


Ingredient matches for Lecarge



Carbidopa

Carbidopa is reported as an ingredient of Lecarge in the following countries:


  • Argentina

  • Peru

Levodopa

Levodopa is reported as an ingredient of Lecarge in the following countries:


  • Argentina

  • Peru

International Drug Name Search

Thursday 17 June 2010

Ciprotan




Ciprotan may be available in the countries listed below.


Ingredient matches for Ciprotan



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Ciprotan in the following countries:


  • Ireland

International Drug Name Search

Saturday 12 June 2010

Lavida




Lavida may be available in the countries listed below.


Ingredient matches for Lavida



Glimepiride

Glimepiride is reported as an ingredient of Lavida in the following countries:


  • Algeria

International Drug Name Search

Tuesday 8 June 2010

Frusenex




Frusenex may be available in the countries listed below.


Ingredient matches for Frusenex



Furosemide

Furosemide is reported as an ingredient of Frusenex in the following countries:


  • India

International Drug Name Search

Friday 28 May 2010

Torasemid Heumann




Torasemid Heumann may be available in the countries listed below.


Ingredient matches for Torasemid Heumann



Torasemide

Torasemide is reported as an ingredient of Torasemid Heumann in the following countries:


  • Germany

International Drug Name Search

Thursday 27 May 2010

Akriderm Genta




Akriderm Genta may be available in the countries listed below.


Ingredient matches for Akriderm Genta



Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Akriderm Genta in the following countries:


  • Russian Federation

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Akriderm Genta in the following countries:


  • Russian Federation

International Drug Name Search

Pefloxacin




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MA03

CAS registry number (Chemical Abstracts Service)

0070458-92-3

Chemical Formula

C17-H20-F-N3-O3

Molecular Weight

333

Therapeutic Category

Antiinfective, quinolin-derivative

Chemical Names

1-Ethyl-6-fluor-7-(4-methyl-1-piperazin-1-yl)-4-oxo-1,4-dihydrochinolin-3-carbonsäure (IUPAC)

1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-methyl-1-piperazinyl)-3-quinolinecarboxylic acid

1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (WHO)

3-Quinolinecarboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-

3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-

Foreign Names

  • Pefloxacinum (Latin)
  • Pefloxacin (German)
  • Péfloxacine (French)
  • Pefloxacino (Spanish)

Generic Names

  • Pefloxacin (OS: USAN, BAN)
  • Pefloxacina (OS: DCIT)
  • Péfloxacine (OS: DCF)
  • EU 5306 (IS)
  • RB 1589 (IS: RogerBellon)
  • Pefloxacin Mesilate (OS: BAN)
  • Pefloxacin Mesylate (OS: USAN)
  • RP 41982 (IS: RhônePoulenc)
  • Pefloxacin Mesilate (PH: BP 2010)
  • Pefloxacin Mesilate Dihydrate (PH: Ph. Eur. 6)
  • Péfloxacine (mésilate de) dihydraté (PH: Ph. Eur. 6)
  • Pefloxacini mesilas dihydricus (PH: Ph. Eur. 6)
  • Pefloxacinmesilat-Dihydrat (PH: Ph. Eur. 6)

Brand Names

  • Abaktal
    Lek, Bosnia & Herzegowina; Lek, Bulgaria; Lek, Czech Republic; Lek, Georgia; Lek, Croatia (Hrvatska); Lek, Lithuania; Lek, Latvia; Lek, Poland; Lek, Romania; Lek, Russian Federation; Sandoz, Slovakia


  • Isofloxin
    Beximco, Bangladesh


  • Nobac
    Ibn Sina, Bangladesh


  • Noflexin
    Novell, Indonesia


  • Oxaflox
    Coronet Crown, Indonesia


  • Pefbid
    Alembic, India


  • Peflacine
    Aventis, Ghana; Aventis, Kenya; Aventis, Nigeria; Aventis, Peru; Aventis, Zimbabwe; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Burkina Faso; Sanofi-Aventis, Benin; Sanofi-Aventis, Central African Republic; Sanofi-Aventis, Congo; Sanofi-Aventis, Cote D'ivoire; Sanofi-Aventis, Cameroon; Sanofi-Aventis, Gabon; Sanofi-Aventis, Guinea; Sanofi-Aventis, Madagascar; Sanofi-Aventis, Mali; Sanofi-Aventis, Mauritania; Sanofi-Aventis, Mauritius; Sanofi-Aventis, Niger; Sanofi-Aventis, Senegal; Sanofi-Aventis, Chad; Sanofi-Aventis, Togo; Sanofi-Aventis, Zaire; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal


  • Pefloksacyna
    Polfa Grodzisk, Poland


  • Peflon
    GlaxoSmithKline, Bangladesh


  • Peflox
    Drug International, Bangladesh


  • Pefloxacin Domesco
    Domesco, Vietnam


  • Pelox
    Wockhardt, Botswana; Wockhardt, Ghana; Wockhardt, India; Wockhardt, Kenya; Wockhardt, Malawi; Wockhardt, Namibia; Wockhardt, Sudan; Wockhardt, Tanzania; Wockhardt, Uganda; Wockhardt, Zambia


  • Pelox-400
    Transatlantic International, Russian Federation


  • Unikpef
    Unique, Russian Federation


  • Bioflen
    Bruluart, Mexico


  • Dexaflox
    Dexa Medica, Indonesia


  • Felox
    Gracia Pharmindo, Indonesia


  • Idrostamin
    Gap, Greece


  • International Apex Pefloxacin
    Duopharma, Philippines


  • Labocton
    Viofar, Greece


  • Niux
    Sanitas, Argentina


  • Peflacin
    Sanofi-Aventis, Brazil; Sanofi-Aventis, Italy


  • Peflacine Injection
    Aventis, Ghana; Aventis, Kenya; Aventis, Nigeria; Aventis, Zimbabwe


  • Peflacine
    Eczacibasi, Turkey; Egis, Poland; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Vietnam


  • Péflacine
    Egis, Hungary; Sanofi-Aventis, France


  • Peflox
    Formenti, Italy


  • Perti
    Biofarma, Venezuela


  • Proflox
    Cipla, India; Cipla, Romania; Cipla, Vietnam

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 25 May 2010

Erythroforte




Erythroforte may be available in the countries listed below.


Ingredient matches for Erythroforte



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erythroforte in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Uro-Plus




Uro-Plus may be available in the countries listed below.


Ingredient matches for Uro-Plus



Norfloxacin

Norfloxacin is reported as an ingredient of Uro-Plus in the following countries:


  • Peru

International Drug Name Search

Monday 24 May 2010

Xepabet




Xepabet may be available in the countries listed below.


Ingredient matches for Xepabet



Gliclazide

Gliclazide is reported as an ingredient of Xepabet in the following countries:


  • Indonesia

International Drug Name Search

Thursday 20 May 2010

Termalgine




Termalgine may be available in the countries listed below.


Ingredient matches for Termalgine



Paracetamol

Paracetamol is reported as an ingredient of Termalgine in the following countries:


  • Turkey

International Drug Name Search

Wednesday 19 May 2010

Apo-Primidone




Apo-Primidone may be available in the countries listed below.


Ingredient matches for Apo-Primidone



Primidone

Primidone is reported as an ingredient of Apo-Primidone in the following countries:


  • Canada

  • New Zealand

International Drug Name Search

Pefloxacin Mesilate




Pefloxacin Mesilate may be available in the countries listed below.


Ingredient matches for Pefloxacin Mesilate



Pefloxacin

Pefloxacin Mesilate (BAN) is also known as Pefloxacin (Rec.INN)

International Drug Name Search

Glossary

BANBritish Approved Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 18 May 2010

Zopiclone Alter




Zopiclone Alter may be available in the countries listed below.


Ingredient matches for Zopiclone Alter



Eszopiclone

Zopiclone is reported as an ingredient of Zopiclone Alter in the following countries:


  • France

International Drug Name Search

Keisamine




Keisamine may be available in the countries listed below.


Ingredient matches for Keisamine



Tranexamic Acid

Tranexamic Acid is reported as an ingredient of Keisamine in the following countries:


  • Japan

International Drug Name Search

Saturday 15 May 2010

Dolvex




Dolvex may be available in the countries listed below.


Ingredient matches for Dolvex



Nimesulide

Nimesulide is reported as an ingredient of Dolvex in the following countries:


  • Ecuador

International Drug Name Search

Lisinopril / Hydrochlorthiazide Alternova




Lisinopril/Hydrochlorthiazide Alternova may be available in the countries listed below.


Ingredient matches for Lisinopril/Hydrochlorthiazide Alternova



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril/Hydrochlorthiazide Alternova in the following countries:


  • Denmark

Lisinopril

Lisinopril is reported as an ingredient of Lisinopril/Hydrochlorthiazide Alternova in the following countries:


  • Denmark

International Drug Name Search

Friday 14 May 2010

Timolol Mylan




Timolol Mylan may be available in the countries listed below.


Ingredient matches for Timolol Mylan



Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Timolol Mylan in the following countries:


  • Netherlands

International Drug Name Search

Tuesday 11 May 2010

Topira-Q




Topira-Q may be available in the countries listed below.


Ingredient matches for Topira-Q



Topiramate

Topiramate is reported as an ingredient of Topira-Q in the following countries:


  • Germany

International Drug Name Search

Sunday 9 May 2010

Mianserin Merck NM




Mianserin Merck NM may be available in the countries listed below.


Ingredient matches for Mianserin Merck NM



Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Mianserin Merck NM in the following countries:


  • Denmark

International Drug Name Search

Bicalutamida Davur




Bicalutamida Davur may be available in the countries listed below.


Ingredient matches for Bicalutamida Davur



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamida Davur in the following countries:


  • Spain

International Drug Name Search

Saturday 8 May 2010

Co-Amiloride Teva




Co-Amiloride Teva may be available in the countries listed below.


Ingredient matches for Co-Amiloride Teva



Amiloride

Amiloride is reported as an ingredient of Co-Amiloride Teva in the following countries:


  • Belgium

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co-Amiloride Teva in the following countries:


  • Belgium

International Drug Name Search

Losartan-Kalium / Hydrochlorothiazid Orifarm




Losartan-Kalium/Hydrochlorothiazid Orifarm may be available in the countries listed below.


Ingredient matches for Losartan-Kalium/Hydrochlorothiazid Orifarm



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Losartan-Kalium/Hydrochlorothiazid Orifarm in the following countries:


  • Germany

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan-Kalium/Hydrochlorothiazid Orifarm in the following countries:


  • Germany

International Drug Name Search

Thursday 6 May 2010

Rilaten




Rilaten may be available in the countries listed below.


Ingredient matches for Rilaten



Rociverine

Rociverine is reported as an ingredient of Rilaten in the following countries:


  • China

  • Colombia

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Italy

  • Nicaragua

  • Panama

International Drug Name Search

Wednesday 5 May 2010

Citrodan




Citrodan may be available in the countries listed below.


Ingredient matches for Citrodan



Magnesium Citrate

Magnesium Citrate is reported as an ingredient of Citrodan in the following countries:


  • Canada

International Drug Name Search

Tuesday 4 May 2010

Topictal




Topictal may be available in the countries listed below.


Ingredient matches for Topictal



Topiramate

Topiramate is reported as an ingredient of Topictal in the following countries:


  • Argentina

International Drug Name Search

Sunday 2 May 2010

Allopurinol-Egis




Allopurinol-Egis may be available in the countries listed below.


Ingredient matches for Allopurinol-Egis



Allopurinol

Allopurinol is reported as an ingredient of Allopurinol-Egis in the following countries:


  • Russian Federation

International Drug Name Search

Friday 23 April 2010

Trichozole




Trichozole may be available in the countries listed below.


Ingredient matches for Trichozole



Metronidazole

Metronidazole is reported as an ingredient of Trichozole in the following countries:


  • New Zealand

International Drug Name Search

Thursday 22 April 2010

Lacril




Lacril may be available in the countries listed below.


Ingredient matches for Lacril



Methylcellulose

Methylcellulose is reported as an ingredient of Lacril in the following countries:


  • Denmark

International Drug Name Search

Dilgard




Dilgard may be available in the countries listed below.


Ingredient matches for Dilgard



Carvedilol

Carvedilol is reported as an ingredient of Dilgard in the following countries:


  • Bangladesh

Diltiazem

Diltiazem is reported as an ingredient of Dilgard in the following countries:


  • Peru

International Drug Name Search

Monday 19 April 2010

Kanamycin Sulfate Injection Meiji




Kanamycin Sulfate Injection Meiji may be available in the countries listed below.


Ingredient matches for Kanamycin Sulfate Injection Meiji



Kanamycin

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kanamycin Sulfate Injection Meiji in the following countries:


  • Thailand

International Drug Name Search

Sunday 18 April 2010

Diprosone


Generic Name: betamethasone topical (bay ta METH a sone)

Brand Names: Alphatrex, Beta-Val, Diprolene, Diprolene AF, Diprosone, Luxiq


What is Diprosone (betamethasone topical)?

Betamethasone is a topical steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.


Betamethasone topical is used to treat the inflammation caused by a number of conditions such as allergic reactions, eczema, and psoriasis. The dental paste form of betamethasone is used to treat mouth ulcers.


Betamethasone topical may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Diprosone (betamethasone topical)?


Use this medication exactly as directed on the label, or as it has been prescribed by your doctor. Do not use the medication in larger amounts or for longer than recommended.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with betamethasone topical can increase the amount of the drug your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions.

Avoid using this medication on your face, near your eyes, or on body areas where you have skin folds or thin skin.


Do not use this medication on a child without a doctor's advice. Children are more sensitive to the effects of betamethasone topical.

Betamethasone topical will not treat a bacterial, fungal, or viral skin infection.


Contact your doctor if your condition does not improve or if it gets worse after using this medication for several days.

What should I discuss with my healthcare provider before using Diprosone (betamethasone topical)?


Do not use this medication if you are allergic to betamethasone.

Before using betamethasone topical, tell your doctor if you are allergic to any drugs, or if you have any type of skin infection.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether betamethasone topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medication on a child without a doctor's advice. Children are more sensitive to the effects of betamethasone topical.

How should I use Diprosone (betamethasone topical)?


Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor. Follow the instructions on your prescription label.


Betamethasone topical will not treat a bacterial, fungal, or viral skin infection.


Wash your hands before and after each application, unless you are using betamethasone topical to treat a hand condition.


Apply a small amount to the affected area and rub it gently into the skin.


Avoid using this medication on your face, near your eyes or mouth, or on body areas where you have skin folds or thin skin.


If you are using the dental paste, apply the medication in a thin layer, just enough to cover the mouth ulcer. The paste may stick better if you dry the mouth ulcer before applying the medication.


Do not cover treated skin areas with a bandage or other covering unless your doctor has told you to. If you are treating the diaper area of a baby, do not use plastic pants or tight-fitting diapers. Covering the skin that is treated with betamethasone topical can increase the amount of the drug your skin absorbs, which may lead to unwanted side effects. Follow your doctor's instructions. Contact your doctor if your condition does not improve or if it gets worse after using this medication for several days. It is important to use betamethasone topical regularly to get the most benefit. Store betamethasone topical at room temperature away from moisture and heat.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine, or if anyone has accidentally swallowed it. An overdose of betamethasone topical applied to the skin is not expected to produce life-threatening symptoms.

What should I avoid while using Diprosone (betamethasone topical)?


Avoid getting this medication in your eyes, mouth, and nose, or on your lips. If it does get into any of these areas, wash with water. Do not use betamethasone topical on sunburned, windburned, irritated, or broken skin. Also avoid using this medication in open wounds.

Avoid using skin products that can cause irritation, such as harsh soaps or shampoos or skin cleansers, hair coloring or permanent chemicals, hair removers or waxes, or skin products with alcohol, spices, astringents, or lime. Do not use other medicated skin products unless your doctor has told you to.


Diprosone (betamethasone topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these signs that you may be absorbing betamethasone topical through your skin or gums:

  • blurred vision, or seeing halos around lights;




  • uneven heartbeats;




  • mood changes;




  • sleep problems (insomnia);




  • weight gain, puffiness in your face; or




  • feeling tired.



Less serious side effects may include:



  • skin redness, burning, itching, or peeling;




  • thinning of your skin; or




  • blistering skin; or




  • stretch marks.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Diprosone (betamethasone topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied betamethasone topical. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Diprosone resources


  • Diprosone Side Effects (in more detail)
  • Diprosone Use in Pregnancy & Breastfeeding
  • Diprosone Drug Interactions
  • Diprosone Support Group
  • 1 Review for Diprosone - Add your own review/rating


  • Diprosone Advanced Consumer (Micromedex) - Includes Dosage Information

  • Beta-Val Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Beta-Val Advanced Consumer (Micromedex) - Includes Dosage Information

  • Diprolene Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Diprolene Prescribing Information (FDA)

  • Diprolene AF Prescribing Information (FDA)

  • Luxiq Prescribing Information (FDA)

  • Luxiq Foam MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Diprosone with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus


Where can I get more information?


  • Your pharmacist can provide more information about betamethasone topical.

See also: Diprosone side effects (in more detail)


Saturday 17 April 2010

Laremid




Laremid may be available in the countries listed below.


Ingredient matches for Laremid



Loperamide

Loperamide is reported as an ingredient of Laremid in the following countries:


  • Poland

International Drug Name Search

Thursday 15 April 2010

Lara




Lara may be available in the countries listed below.


Ingredient matches for Lara



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Lara in the following countries:


  • Peru

International Drug Name Search

Wednesday 14 April 2010

Ketros




Ketros may be available in the countries listed below.


Ingredient matches for Ketros



Ketoprofen

Ketoprofen is reported as an ingredient of Ketros in the following countries:


  • Indonesia

International Drug Name Search

Equiworm P




Equiworm P may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Equiworm P



Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Equiworm P in the following countries:


  • Netherlands

International Drug Name Search

Wednesday 7 April 2010

Bisolax


Generic Name: bisacodyl (bis AK oh dil)

Brand Names: Alophen, Bisac-Evac, Bisco-Lax, Carters Little Pills, Correctol, Doxidan Tablet, Dulcolax Laxative, Evac-U-Gen, Ex-lax Ultra, Feen-A-Mint, Fleet Bisacodyl, Gen Lax, Gentlax Tablet, Gentle Laxative, Laxative Gentle Suppositories, Magic Bullet, Modane, Veracolate


What is Bisolax (bisacodyl)?

Bisacodyl is a laxative that stimulates bowel movements.


Bisacodyl is used to treat constipation or to empty the bowels before surgery, colonoscopy, x-rays, or other intestinal medical procedure.


Bisacodyl may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Bisolax (bisacodyl)?


Do not use bisacodyl if you have stomach (abdominal) pain, nausea, or vomiting, unless directed by a doctor.

If you notice a sudden change in bowel habits that persists over a period of 2 weeks, consult your healthcare provider before using a laxative.


Bisacodyl products should not be used for longer than one week, unless otherwise directed by your healthcare provider.

Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a more serious condition. Stop using bisacodyl and contact your healthcare provider.


What should I discuss with my healthcare provider before using Bisolax (bisacodyl)?


You should not use this medication if you are allergic to bisacodyl, or if you have:

  • severe stomach pain, nausea, or vomiting;




  • a perforated bowel;




  • a blockage in your intestines;




  • fructose or galactose intolerance;




  • an allergy to yellow food dye;




  • severe constipation or dehydration;




  • inflammatory bowel disease, toxic megacolon; or




  • a sudden change in bowel habits lasting 2 weeks or longer.



People with eating disorders (such as anorexia or bulimia) should not use this medication without the advice of a doctor.


If you have any of these other conditions, you may need a dose adjustment or special tests to safely use bisacodyl:



  • kidney disease;




  • trouble swallowing;




  • a history of bowel obstruction, diverticulitis, ulcerative colitis, or other intestinal disorder; or




  • if you are taking a diuretic ("water pill").




Do not use bisacodyl without telling your doctor if you are pregnant. Do not use bisacodyl without telling your doctor if you are breast-feeding a baby. Do not give this medication to a child without the advice of a doctor.

When used to treat constipation, bisacodyl is only part of a complete program of treatment that may also include diet and exercise. Follow your doctor's instructions very closely.


How should I use Bisolax (bisacodyl)?


Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.


For best results, take bisacodyl on an empty stomach, or at bedtime. Do not crush, chew, or break the enteric-coated tablet. Swallow it whole. The enteric-coated pill has a special coating to protect your stomach. Breaking the pill could damage this coating. Do not take a bisacodyl rectal (enema or suppository) by mouth. It is for use only in your rectum.

Try to use the rectal form of this medicine at a time when you can lie down afterward and hold the medicine in. Avoid using the bathroom during this time.


If you are using bisacodyl before surgery or a medical procedure, follow your doctor's instructions about the timing of your dose (the number of days or hours) before your procedure.

Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Lie on your side and gently insert the suppository pointed end first. For best results, hold in the suppository for a 15 to 20 minutes. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in. Avoid using the bathroom just after you have inserted the suppository.


Shake the rectal enema gently just before use. Remove the protective cap from the applicator tip. You may use the enema lying down or seated on a toilet. Gently insert the tip into your rectum and lightly squeeze the bottle to release the enema. Hold the enema in for a few minutes and then release into the toilet.


The rectal forms of bisacodyl should produce a bowel movement within 15 minutes to 1 hour.


The tablet form of bisacodyl should produce a bowel movement within 6 to 12 hours, or overnight when taken at bedtime.


Call your doctor if you do not have a bowel movement after using this medication. Do not use bisacodyl for more than 7 days in a row unless your doctor tells you to. Store bisacodyl at room temperature away from moisture and heat.

What happens if I miss a dose?


Since bisacodyl is used only once or as needed, you are not likely to be on a dosing schedule.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include watery diarrhea, stomach cramps, muscle weakness, or urinating less than usual.


What should I avoid while using Bisolax (bisacodyl)?


Avoid using any other medications within 2 hours before or after using bisacodyl.


Avoid drinking milk within 1 hour after using bisacodyl.

Bisolax (bisacodyl) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

  • urinating less than usual or not at all;




  • drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting;




  • swelling, weight gain, feeling short of breath;




  • rectal bleeding;




  • severe stomach pain or cramps, severe or ongoing diarrhea or vomiting; or




  • low potassium (confusion, uneven heart rate, extreme thirst, increased urination, leg discomfort, muscle weakness or limp feeling).



Less serious side effects may include:



  • dizziness, weakness;




  • increased thirst;




  • mild stomach pain, gas, indigestion;




  • diarrhea or loose stools;




  • mild nausea; or




  • skin rash.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Bisolax (bisacodyl)?


There may be other drugs that can interact with bisacodyl. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Bisolax resources


  • Bisolax Side Effects (in more detail)
  • Bisolax Use in Pregnancy & Breastfeeding
  • Bisolax Drug Interactions
  • Bisolax Support Group
  • 0 Reviews for Bisolax - Add your own review/rating


  • Bisacodyl Prescribing Information (FDA)

  • Bisacodyl Professional Patient Advice (Wolters Kluwer)

  • Bisacodyl Monograph (AHFS DI)

  • Bisacodyl MedFacts Consumer Leaflet (Wolters Kluwer)

  • Evac-u-gen Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Bisolax with other medications


  • Bowel Preparation
  • Constipation


Where can I get more information?


  • Your pharmacist can provide more information about bisacodyl.

See also: Bisolax side effects (in more detail)


Monday 5 April 2010

Fluconazol Pharmed




Fluconazol Pharmed may be available in the countries listed below.


Ingredient matches for Fluconazol Pharmed



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Pharmed in the following countries:


  • Peru

International Drug Name Search

Thursday 1 April 2010

Rosula Gel


Pronunciation: SUL-fa-SEET-a-mide/SUL-fur/UE-REE-a
Generic Name: Sulfacetamide/Sulfur
Brand Name: Examples include Rosula and Sulfatol


Rosula Gel is used for:

Treating acne, rosacea, and seborrhea. It may also be used for other conditions as determined by your doctor.


Rosula Gel is a sulfonamide antibiotic and keratolytic combination. It works by killing bacteria and shedding the top layer of skin.


Do NOT use Rosula Gel if:


  • you are allergic to any ingredient in Rosula Gel or sulfur

  • you have had an allergic reaction to any other sulfonamide medicine, such as acetazolamide, celecoxib, certain diuretics (eg, hydrochlorothiazide), glyburide, probenecid, sulfamethoxazole, valdecoxib, or zonisamide

  • you have kidney disease

Contact your doctor or health care provider right away if any of these apply to you.



Before using Rosula Gel:


Some medical conditions may interact with Rosula Gel. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have eczema or a history of lupus

Some MEDICINES MAY INTERACT with Rosula Gel. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Silver-containing products (eg, silver sulfadiazine) because they may decrease Rosula Gel's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rosula Gel may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Rosula Gel:


Use Rosula Gel as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Rosula Gel is for use on the skin only. Rosula Gel may stain clothing and the skin if too much is used.

  • Wash your hands before and after using Rosula Gel, unless your hands are part of the treated area.

  • Gently wash and dry the affected areas. Apply a thin film of Rosula Gel to the affected areas, as directed by your doctor.

  • Continue to use Rosula Gel even if your condition improves. Do not miss any doses.

  • If you miss a dose of Rosula Gel, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Rosula Gel.



Important safety information:


  • It may take several days for Rosula Gel to work fully.

  • Rosula Gel is for external use only. Avoid getting it in your eyes, nose, or mouth. If you get it in your eyes, rinse immediately with cool water.

  • Talk with your doctor before you use any other medicines or cleansers on your skin.

  • Do not apply Rosula Gel to open wounds or to damaged or burned skin without first checking with your doctor.

  • If you use topical products too often, your condition may become worse.

  • Long-term or repeated use of Rosula Gel may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.

  • Rosula Gel should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Rosula Gel while you are pregnant. It is not known if Rosula Gel is found in breast milk after topical use. If you are or will be breast-feeding while you use Rosula Gel, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Rosula Gel:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild irritation, stinging, or burning of the skin.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); cracked or extremely dry skin; fever; joint pain; red, swollen, scaling, or blistered skin; severe diarrhea; severe skin irritation; sores in the mouth; unusual bruising; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Rosula Gel may be harmful if swallowed. Symptoms of ingestion may include change in the amount of urine; nausea; vomiting.


Proper storage of Rosula Gel:

Store Rosula Gel at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not freeze. Keep Rosula Gel out of the reach of children and away from pets.


General information:


  • If you have any questions about Rosula Gel, please talk with your doctor, pharmacist, or other health care provider.

  • Rosula Gel is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rosula Gel. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rosula resources


  • Rosula Use in Pregnancy & Breastfeeding
  • Rosula Drug Interactions
  • Rosula Support Group
  • 0 Reviews for Rosula - Add your own review/rating


Compare Rosula with other medications


  • Acne
  • Rosacea
  • Seborrheic Dermatitis